Wendy B. Young

RAPP

Wendy B. Young serves as an insider at Rapport Therapeutics, Inc. Common Stock (RAPP). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$140.3K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$140.3K

Companies Traded

RAPP

Active Period

Mar 2025 – Sep 2025

2 total trades

Most Recent

Buy RAPP

Sep 11, 2025 · $79.1K

Wendy B. Young's Insider Trading at Rapport Therapeutics, Inc. Common Stock (RAPP)

Buys

2 · $140.3K

Sells

0 · $0.00

Total Shares Bought

9,500

Total Shares Sold

RAPP Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 11, 2025	Buy	3,500	$22.60	$79.1K	9,500
Mar 13, 2025	Buy	6,000	$10.21	$61.2K	6,000

Related Insiders

Abraham Ceesay

director, officer: Chief Executive Officer

RAPPSell · Sep 9, 2026

Krishnaswamy Yeleswaram

officer: Chief Development Officer

RAPPSell · Aug 26, 2026

Cheryl Gault

officer: Chief Operating Officer

RAPPSell · Jul 1, 2026

Third Rock Ventures V, L.P.

10 percent owner

RAPPSell · May 28, 2026

David Bredt

officer: Chief Scientific Officer

RAPPSell · Feb 19, 2026

Explore More Insider Trading Data

RAPP Insider Trading Activity

View all insider trades at Rapport Therapeutics, Inc. Common Stock

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity